Learn more about it.
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction
Sent on 25 September 2019
Takis Innovation and Health Technologies awarded in Lazio Region
Sent on 16 July 2019
Takis Antibodies TraZimAb and Rever3mAb moving forward!
Sent on 10 July 2019
Takis Biotech Research moving forward!
Sent on 19 June 2019
TAKIS announces a collaboration partnership with TRIANNI for Human Therapeutic Antibody generation
Sent on 10 April 2019
Takis & VITARES Formazione - Dott. Marco Crescenzi - "Promuovere la Ricerca Scientifica del Lazio nel Pubblico e nel Privato: le Core facilities dell’ISS"
Sent on 10 October 2018
LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines
Sent on 29 September 2018
Incontra TAKIS al congresso FISV a Roma!
Sent on 18 September 2018
Results 1 - 8 out of 8